Skip to main content

Table 2 Evaluation of learning results by 10 × 10 stratified cross-validation of DT and ILP programs

From: Integrative relational machine-learning for understanding drug side-effect profiles

SEP

DT

ILP

 

Acc

Spec

Sens

Acc

Spec

Sens

SEP_1

0.65

0.86

0.39

0.61

0.63

0.6

SEP_2

0.69

0.88

0.4

0.63

0.69

0.54

SEP_3

0.71

0.88

0.47

0.71

0.77

0.63

SEP_4

0.66

0.89

0.32

0.62

0.7

0.51

SEP_5

0.68

0.88

0.38

0.64

0.7

0.54

SEP_6

0.68

0.87

0.39

0.61

0.69

0.49

SEP_7

0.65

0.86

0.32

0.6

0.67

0.49

SEP_8

0.7

0.87

0.44

0.67

0.73

0.57

SEP_9

0.69

0.84

0.46

0.69

0.75

0.59

SEP_10

0.7

0.89

0.4

0.65

0.76

0.47

SEP_11

0.7

0.88

0.44

0.7

0.82

0.45

SEP_12

0.71

0.88

0.45

0.7

0.76

0.61

SEP_13

0.67

0.88

0.35

0.66

0.74

0.54

SEP_14

0.69

0.89

0.39

0.63

0.71

0.51

SEP_15

0.71

0.9

0.43

0.69

0.76

0.6

SEP_16

0.69

0.89

0.39

0.66

0.72

0.57

SEP_17

0.74

0.89

0.52

0.65

0.74

0.51

SEP_18

0.65

0.87

0.34

0.61

0.69

0.5

SEP_19

0.74

0.91

0.47

0.72

0.77

0.64 0

SEP_20

0.71

0.89

0.44

0.64

0.73

0.51

SEP_21

0.72

0.9

0.46

0.64

0.72

0.54

SEP_22

0.65

0.88

0.32

0.61

0.69

0.48

SEP_23

0.71

0.89

0.43

0.63

0.7

0.51

SEP_24

0.68

0.87

0.4

0.62

0.71

0.5

SEP_25

0.71

0.9

0.43

0.65

0.72

0.56

SEP_26

0.69

0.88

0.4

0.62

0.69

0.52

Average

0.67

0.83

0.43

0.65

0.72

0.54

  1. Acc: accuracy, Spec: specificity, Sens: sensitivity.